Organizers claimed that nearly 2 million Hong Kong protesters took to the streets Sunday in a rally to demand the city's top official resign a day after she suspended — but...China Politicsread more
African swine fever, which has already ravaged pig herds in China and pushed up food prices there, could also drive up inflation in the other emerging markets, according to...Asia Economyread more
Consumer goods giant Unilever has taken the unusual step of having some of its marketing staff read their own DNA profiles to see whether finding out about their heritage has...Marketing.Media.Moneyread more
Stocks in Asia traded mixed on Monday as investors await a U.S. Federal Reserve meeting set to happen later in the week stateside.Asia Marketsread more
In the survey, 66% of Democratic primary voters say they'd be enthusiastic or comfortable about Biden as their nominee to take on President Trump in the 2020 election. Just...Politicsread more
Heavy rains caused unprecedented delays in planting this year and contributed to record floods across the central United States.Agricultureread more
Target's registers were down on Saturday for several hours preventing customers from checking out.Retailread more
Although Cook did not mention companies by name, his commencement speech in Silicon Valley's backyard mentioned data breaches, privacy violations, and even made reference to...Technologyread more
U.S. ambassador to Israel David Friedman called the gesture a "birthday present" to Trump, who turned 73 on Friday.Politicsread more
The outlook for Germany's economy and political stability are more uncertain than ever, writes Michael Ivanovitch.World Economyread more
The agreement, which is on the framework for the plan of adjustment, provide for more than a 60% average haircut for all $35 billion, a 36% haircut on pre-2012 general...Bondsread more
Here's one guy who REALLY doesn't want the stock market to tank any further — or he might get locked up.
Pharma bad boy Martin Shkreli has used his E-Trade brokerage account — which contained a cool $45 million as of Wednesday — to secure the $5 million bond that has kept him out of jail since mid-December, when he was indicted on federal securities fraud charges.
A magistrate judge in Brooklyn, New York, agreed to accept Shkreli's account as collateral for the bond, but placed a number of tight restrictions on the deal. Shrekli had until Friday to determine what assets he wanted to use to secure his release.
The judge, Kiyo Matsumoto, barred Shkreli, any of his relatives, employees or other associates from selling off or transferring any of the holdings in the E-Trade account, or using the account to secure any other debt. Matsumoto also ordered E-Trade to let federal prosecutors in Brooklyn know if the assets in the account are valued at less than $5 million.
Shkreli, 32, was arrested last month on charges related to his actions at the hedge fund he previously ran, and the pharmaceuticals firm, Retrophin, that he founded and ran until his ouster by the company's board of directors in 2014. Shkreli is accused of looting Retrophin to pay off investors whom he was suspected of defrauding at the hedge fund, and also is accused of misrepresenting the amount of assets his fund had under management.
He has denied the charges.
Shkreli first came to public attention in September when it was revealed that his new company, Turing Pharmaceuticals, had hiked the prices of a drug called Daraprim by more than 5,000 percent, from $13.50 per pill to $750.
Shkreli resigned as Turing's CEO after his arrest. He was fired days later as CEO of KaloBios, another company he had recently purchased.